{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:04:32Z","timestamp":1759579472764,"version":"3.38.0"},"reference-count":59,"publisher":"American Veterinary Medical Association (AVMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To evaluate canine histiocytic sarcoma cell lines and tumor samples for dysregulation of the Kit\/stem-cell factor (SCF), Flt3\/Flt3 ligand (Flt3L), and Met\/hepatocyte growth factor (HGF) receptor tyrosine kinase signaling pathways, as these are known to contribute to the differentiation and survival of normal dendritic cells as well as malignant transformation of dendritic cells in mouse models.<\/jats:p>\n<jats:p><jats:bold>Sample Population<\/jats:bold>\u20144 histiocytic sarcoma tumor cell lines and 35 formalin-fixed histiocytic sarcoma specimens obtained from dogs.<\/jats:p>\n<jats:p><jats:bold>Procedure<\/jats:bold>\u2014Histiocytic sarcoma cell lines were evaluated for expression of Kit\/SCF, Flt3\/Flt3L, and Met\/HGF by use of reverse transcriptase-PCR procedures. Histiocytic sarcoma cell lines and tumor samples were evaluated for mutations in Kit, Flt3, and Met by use of PCR analysis of genomic DNA, followed by both sequencing and fluorescent PAGE for deletions or internal tandem duplications. The ability of the multitargeted split-kinase inhibitor SU11654 to block proliferation and induce apoptosis of histiocytic sarcoma cell lines was also evaluated.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014No mutations in Kit, Flt3, and Met were identified in any of the cell lines or tumor samples evaluated. Furthermore, SU11654 did not induce cellcycle arrest or apoptosis of histiocytic sarcoma lines, even at supratherapeutic doses.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014These data suggest that dysregulation of Kit\/SCF, Flt3\/Flt3L, and Met\/HGF signaling pathways is unlikely to occur in histiocytic sarcomas of dogs and that inhibitors of the Kit, Flt3, and Met pathways are unlikely to provide clinical benefit to dogs with histiocytic sarcomas.<\/jats:p>","DOI":"10.2460\/ajvr.67.4.633","type":"journal-article","created":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:57:00Z","timestamp":1143853020000},"page":"633-641","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs"],"prefix":"10.2460","volume":"67","author":[{"given":"Regina","family":"Zavodovskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert T.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron L. R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May B.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1354\/vp.39-1-74","article-title":"Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs","volume":"39","author":"Affolter","year":"2002"},{"key":"ref2","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/030098589303000306","article-title":"Disseminated malignant histiocytosis in a Golden Retriever: clinicopathologic, ultrastructural, and immunohistochemical findings","volume":"30","author":"Hayden","year":"1993"},{"key":"ref3","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/030098588602300101","article-title":"Malignant histiocytosis of Bernese Mountain Dogs","volume":"23","author":"Moore","year":"1986"},{"key":"ref4","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1748-5827.1995.tb02838.x","article-title":"Inheritance of histiocytosis in Bernese Mountain Dogs","volume":"36","author":"Padgett","year":"1995"},{"key":"ref5","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/vr.138.18.440","article-title":"Malignant histiocytosis in three Bernese Mountain Dogs","volume":"138","author":"Ramsey","year":"1996"},{"key":"ref6","series-title":"J Am Vet Med Assoc","first-page":"1041","article-title":"Malignant histiocytosis in Bernese Mountain Dogs","volume":"188","author":"Rosin","year":"1986"},{"key":"ref7","series-title":"Vet Q","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01652176.1993.9694387","article-title":"Clinical and radiographic manifestations of canine malignant histiocytosis","volume":"15","author":"Schmidt","year":"1993"},{"key":"ref8","series-title":"J Am Vet Med Assoc","first-page":"919","article-title":"Malignant histiocytosis in four dogs","volume":"187","author":"Wellman","year":"1985"},{"key":"ref9","series-title":"Med Pediatr Oncol","first-page":"157","article-title":"Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic\/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society","volume":"29","author":"Favara","year":"1997"},{"key":"ref10","series-title":"Hematol Oncol Clin North Am","first-page":"445","article-title":"Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion","volume":"12","author":"Gogusev","year":"1998"},{"key":"ref11","series-title":"Curr Opin Hematol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00062752-200101000-00001","article-title":"Malignant histiocytosis","volume":"8","author":"Schmidt","year":"2001"},{"key":"ref12","series-title":"Crit Rev Oncog","first-page":"595","article-title":"Hematopoietic receptors of class III receptor-type tyrosine kinases","volume":"4","author":"Rosnet","year":"1993"},{"key":"ref13","series-title":"Blood","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1182\/blood.V82.4.1110.1110","article-title":"Human FLT3\/FLK2 gene: cDNA cloning and expression in hematopoietic cells","volume":"82","author":"Rosnet","year":"1993"},{"key":"ref14","series-title":"Cell","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990"},{"key":"ref15","series-title":"Annu Rev Biochem","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.bi.57.070188.002303","article-title":"Growth factor receptor tyrosine kinases","volume":"57","author":"Yarden","year":"1988"},{"key":"ref16","series-title":"Blood","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood.V91.4.1101","article-title":"c-kit ligand and Flt3 ligand: stem\/progenitor cell factors with overlapping yet distinct activities","volume":"91","author":"Lyman","year":"1998"},{"key":"ref17","series-title":"Int J Hematol","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0925-5710(95)00389-A","article-title":"Biology of flt3 ligand and receptor","volume":"62","author":"Lyman","year":"1995"},{"key":"ref18","series-title":"Adv Immunol","first-page":"1","article-title":"The kit ligand, stem cell factor","volume":"55","author":"Galli","year":"1994"},{"key":"ref19","series-title":"Curr Opin Hematol","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00062752-200105000-00004","article-title":"Role of hematopoietic growth factors\/flt3 lig- and in expansion and regulation of dendritic cells","volume":"8","author":"McKenna","year":"2001"},{"key":"ref20","series-title":"Blood","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood.V92.6.2003","article-title":"Leukemic predisposition of mice transplanted with gene-modified hematopoietic precursors expressing flt3 ligand","volume":"92","author":"Hawley","year":"1998"},{"key":"ref21","series-title":"Blood","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase","volume":"88","author":"Kitayama","year":"1996"},{"key":"ref22","series-title":"Int Arch Allergy Immunol","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000237541","article-title":"c-kit mutation in a population of patients with mastocytosis","volume":"113","author":"Nagata","year":"1997"},{"key":"ref23","series-title":"Leuk Res","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001"},{"key":"ref24","series-title":"Exp Hematol","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0301-472X(98)00075-7","article-title":"Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit","volume":"27","author":"London","year":"1999"},{"key":"ref25","series-title":"J Invest Dermatol","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1523-1747.1999.00488.x","article-title":"Clustering of activating mutations in c-KIT's juxtamembrane coding region of canine mast cell neoplasms","volume":"112","author":"Ma","year":"1999"},{"key":"ref26","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002"},{"key":"ref27","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2460\/ajvr.2002.63.1718","article-title":"Prevalence and signficance of kit internal tandem duplications in canine mast cell tumors","volume":"63","author":"Downing","year":"2002"},{"key":"ref28","series-title":"Leukemia","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.leu.2401241","article-title":"Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan","volume":"13","author":"Iwai","year":"1999"},{"key":"ref29","series-title":"Leukemia","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakoa","year":"1996"},{"key":"ref30","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF00296360","article-title":"Coexpression of stem cell factor and its receptor c-kit in human malignant glioma cell lines","volume":"89","author":"Stanulla","year":"1995"},{"key":"ref31","series-title":"Cell Growth Differ","first-page":"769","article-title":"Coexpression of the c-kit and stem cell factor genes in breast carcinomas","volume":"6","author":"Hines","year":"1995"},{"key":"ref32","series-title":"Oncogene","first-page":"2291","article-title":"Co-expression of the stem cell factor and the c-kit genes in small cell lung cancer","volume":"6","author":"Hibi","year":"1991"},{"key":"ref33","series-title":"Blood","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-1\/Flk2) in human leukemias","volume":"87","author":"Carow","year":"1996"},{"key":"ref34","series-title":"Leukemia","first-page":"588","article-title":"Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells","volume":"10","author":"Drexler","year":"1996"},{"key":"ref35","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1040-8428(98)00019-5","article-title":"Hepatocyte growth factor\/scatter factor, its molecular, cellular and clinical implications in cancer","volume":"29","author":"Jiang","year":"1999"},{"key":"ref36","series-title":"Cytokine Growth Factor Rev","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S1359-6101(01)00029-6","article-title":"Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition","volume":"13","author":"Maulik","year":"2002"},{"key":"ref37","series-title":"Biochem Biophys Res Commun","first-page":"331","article-title":"Hepatocyte growth factor\/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchor-age-independent growth of SV-40 transformed RPTE","volume":"174","author":"Kan","year":"1991"},{"key":"ref38","series-title":"Cell","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0092-8674(91)90363-4","article-title":"Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor","volume":"67","author":"Montesano","year":"1991"},{"key":"ref39","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1083\/jcb.111.5.2097","article-title":"Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells","volume":"111","author":"Weidner","year":"1990"},{"key":"ref40","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1073\/pnas.90.5.1937","article-title":"Scatter factor induces blood vessel formation in vivo","volume":"90","author":"Grant","year":"1993"},{"key":"ref41","series-title":"Trends Cell Biol","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(98)01359-2","article-title":"Developmental roles of HGF\/SF and its receptor, the c-Met tyrosine kinase","volume":"8","author":"Birchmeier","year":"1998"},{"key":"ref42","series-title":"Nat Rev Mol Cell Biol","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003"},{"key":"ref43","series-title":"Lung Cancer","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-5002(98)00007-5","article-title":"Differential expression of Met\/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers","volume":"20","author":"Tsao","year":"1998"},{"key":"ref44","series-title":"J Pathol","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q","article-title":"Expression of Met protein in thyroid tumours","volume":"180","author":"Ruco","year":"1996"},{"key":"ref45","series-title":"J Pathol","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.847","article-title":"Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis","volume":"194","author":"Ruco","year":"2001"},{"key":"ref46","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997"},{"key":"ref47","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/sj.onc.1203455","article-title":"Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas","volume":"19","author":"Di Renzo","year":"2000"},{"key":"ref48","series-title":"Cell Cycle","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4161\/cc.4.4.1590","article-title":"A mouse model of activating Met mutations","volume":"4","author":"Graveel","year":"2005"},{"key":"ref49","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"17198","DOI":"10.1073\/pnas.0407651101","article-title":"Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele","volume":"101","author":"Graveel","year":"2004"},{"key":"ref50","series-title":"Vet Comp Pathol","article-title":"Characterization, expression, and function of c-Met in canine spontaneous cancers","author":"Liao","year":"2005"},{"key":"ref51","series-title":"Blood","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1182\/blood-2001-12-0350","article-title":"Inhibition of constitutively active forms of mutant Kit by multi-targeted indolinone kinase inhibitors","volume":"100","author":"Liao","year":"2002"},{"key":"ref52","series-title":"J Vet Diagn Invest","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/104063870401600201","article-title":"Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis","volume":"16","author":"Jones","year":"2004"},{"key":"ref53","series-title":"Clin Cancer Res","first-page":"2755","article-title":"Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies","volume":"9","author":"London","year":"2003"},{"key":"ref54","series-title":"Proc Am Soc Hem","first-page":"497","article-title":"SUGEN kinase inhibitors SU5416 and SU11248 inhibit Flt3 signaling: therapeutic application in AML","volume":"42","author":"O'Farrell","year":"2001"},{"key":"ref55","series-title":"Blood","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1182\/blood-2002-07-2307","article-title":"SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo","volume":"101","author":"O'Farrell","year":"2003"},{"key":"ref56","series-title":"Vet Comp Onc","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1476-5810.2004.00059.x","article-title":"Kinase inhibitors in cancer therapy","volume":"2","author":"London","year":"2004"},{"key":"ref57","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004"},{"key":"ref58","series-title":"Cell Mol Life Sci","first-page":"2932","article-title":"Normal and oncogenic FLT3","volume":"61","author":"Naoe","year":"2004"},{"key":"ref59","series-title":"J Allergy Clin Immunol","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics","volume":"114","author":"Akin","year":"2004"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/4\/ajvr.67.4.633.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/4\/ajvr.67.4.633.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/4\/ajvr.67.4.633.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:14:41Z","timestamp":1741349681000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/4\/ajvr.67.4.633.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":59,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.67.4.633","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}